Difference between revisions of "Fluoroquinolones"

 
(9 intermediate revisions by 5 users not shown)
Line 1: Line 1:
* UTI (2nd line)
+
==Indications==
* Prostatitis
+
*[[UTI]] (2nd line)
* Chlamydia
+
*[[Prostatitis]]
* PID
+
*[[Chlamydia]]
* Traveler's diarrhea
+
*[[PID]]
 +
*[[Traveler's Diarrhea]]
 +
 
 +
==Adverse Effects==
 +
*Common adverse effects
 +
**GI and neuro toxicity
 +
**Rash
 +
**QT prolongation
 +
**Hyper/hypoglycemia
 +
**Hematologic toxicity
 +
**Depression/Suicidality
 +
*Black box warning from US FDA
 +
**Tendonitis and tendon rupture<ref>Gültuna S. et al. Ciprofloxacin induced tendinitis. J Clin Rheumatol. 2009;15 (4): 201-2</ref>
 +
**Peripheral Neuropathy<ref>Food and Drug Administration: Drug safety announcement about fluoroquinolones and possible peripheral neuropathy [http://www.fda.gov/downloads/Drugs/DrugSafety/UCM365078.pdf PDF]</ref>
  
 
{{Template:Clinically Utilized Antibiotics}}
 
{{Template:Clinically Utilized Antibiotics}}
Line 10: Line 23:
 
*[[Antibiotics (Main)]]
 
*[[Antibiotics (Main)]]
  
==Source==
+
==External Links==
Goodman & Gilman's Pharmacology
+
*[http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm126085.htm FDA info for Health Professionals]
 +
 
 +
==References==
 +
<references/>
  
 
[[Category:ID]]
 
[[Category:ID]]
[[Category:Drugs]]
+
[[Category:Pharmacology]]

Latest revision as of 00:02, 16 November 2018

Indications

Adverse Effects

  • Common adverse effects
    • GI and neuro toxicity
    • Rash
    • QT prolongation
    • Hyper/hypoglycemia
    • Hematologic toxicity
    • Depression/Suicidality
  • Black box warning from US FDA
    • Tendonitis and tendon rupture[1]
    • Peripheral Neuropathy[2]

See Also

External Links

References

  1. Gültuna S. et al. Ciprofloxacin induced tendinitis. J Clin Rheumatol. 2009;15 (4): 201-2
  2. Food and Drug Administration: Drug safety announcement about fluoroquinolones and possible peripheral neuropathy PDF